Who exports Eriacta 100 Mg globally?

Eriacta 100 mg is a medication that contains Sildenafil (the same active ingredient as Viagra), and is used primarily to treat erectile dysfunction (ED). It works by increasing blood flow to the penis to help a man get and maintain an erection when sexually aroused. Eriacta is manufactured by Cipla Limited, an Indian multinational pharmaceutical company that produces a wide range of generic medications. Cipla is a well-known and trusted name in the pharmaceutical industry, especially for its generic versions of branded medications like Sildenafil (Viagra), tadalafil (Cialis), and other ED treatments. Who Exports Eriacta 100 mg Globally? Cipla and its authorized distributors are responsible for the global export of Eriacta 100 mg. Cipla supplies medications to various countries, typically through both direct sales and third-party distributors. The medication is available in many countries, often as a generic Eriacta 100 mg to Viagra. Markets Where Eriacta is Available: India (where it is produced) Middle Eastern Countries (e.g., UAE, Saudi Arabia) Southeast Asia (e.g., Thailand, Indonesia, Malaysia) African Countries (e.g., South Africa) Europe and South America: In some European and South American countries, Eriacta may be available through online pharmacies or distributors, though its availability can vary.